Hypertension, Blood Pressure Variability, and Target Organ Lesion

Current Hypertension Reports

Volumn 18, Issue 4, 2016, Pages

  Irigoyen, Maria Cláudia ^a   De Angelis, Kátia ^b   dos Santos, Fernando ^a   Dartora, Daniela R ^c   Rodrigues, Bruno ^d   Consolim Colombo, Fernanda Marciano ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE NOVE DE JULHO   (Brazil)

^c INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Autonomic dysfunction; Blood pressure variability; Hypertension; Target organ damage

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS PERINDOPRIL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CHLORDIAZEPOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DONEPEZIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; KETANSERIN; LACIDIPINE; LERCANIDIPINE; LOSARTAN; NITRENDIPINE; OLMESARTAN; PLACEBO; PYRIDOSTIGMINE; RAMIPRIL; RESERPINE; TELMISARTAN; THIAZIDE DIURETIC AGENT; TRIAMTERENE; UNINDEXED DRUG; VALSARTAN; ANTIHYPERTENSIVE AGENT;

AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; ELEVATED BLOOD PRESSURE; HUMAN; HYPERTENSION; NONHUMAN; ORGAN INJURY; REVIEW; RISK REDUCTION; TARGET ORGAN DAMAGE; ANIMAL; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; PATHOPHYSIOLOGY; RISK FACTOR;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 84961775235     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-016-0642-9     Document Type: Review

References (130)

1. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20. doi:10.1001/jama.2013.284427.
2. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5(1):93–8.
3. Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010;55(4):1049–57. doi:10.1161/HYPERTENSIONAHA.109.140798.
4. Parati G, Ochoa JE, Bilo G. Blood pressure variability, cardiovascular risk, and risk for renal disease progression. Curr Hypertens Rep. 2012;14(5):421–31. doi:10.1007/s11906-012-0290-7.
5. Dolan E, O’Brien E. Is it daily, monthly, or yearly blood pressure variability that enhances cardiovascular risk? Curr Cardiol Rep. 2015;17(11):93. doi:10.1007/s11886-015-0649-x.
6. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10(3):143–55. doi:10.1038/nrcardio.2013.1.
7. Dolan E, Stanton AV, Thom S, Caulfield M, Atkins N, McInnes G, et al. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients—an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens. 2009;27(4):876–85. doi:10.1097/HJH.0b013e328322cd62.
8. Diaz KM, Tanner RM, Falzon L, Levitan EB, Reynolds K, Shimbo D, et al. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014;64(5):965–82. doi:10.1161/HYPERTENSIONAHA.114.03903.
9. Su DF, Miao CY. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Trends Pharmacol Sci. 2005;26(8):388–90. doi:10.1016/j.tips.2005.06.003.
10. Grassi G, Bombelli M, Brambilla G, Trevano FQ, Dell’oro R, Mancia G. Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep. 2012;14(4):333–8. doi:10.1007/s11906-012-0273-8. The authors performed a extense review of the mechanisms linking total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension. The great scientific contribution of the group in this area must be highlighted.
11. Nagai M, Hoshide S, Dote K, Kario K. Visit-to-visit blood pressure variability and dementia. Geriatr Gerontol Int. 2015;15 Suppl 1:26–33. doi:10.1111/ggi.12660.
12. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005;19(10):801–7. doi:10.1038/sj.jhh.1001903.
13. Juhanoja EP, Niiranen TJ, Johansson JK, Puukka PJ, Jula AM. Agreement between ambulatory, home, and office blood pressure variability. J Hypertens. 2016;34(1):61–7. doi:10.1097/HJH.0000000000000772.
14. Wei FF, Li Y, Zhang L, Xu TY, Ding FH, Wang JG, et al. Beat-to-beat, reading-to-reading, and day-to-day blood pressure variability in relation to organ damage in untreated Chinese. Hypertension. 2014;63(4):790–6. doi:10.1161/HYPERTENSIONAHA.113.02681.
15. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M, et al. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med. 1992;152(9):1855–60.
16. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation. 1997;95(6):1464–70.
17. Madden JM, O’Flynn AM, Dolan E, Fitzgerald AP, Kearney PM. Short-term blood pressure variability over 24 h and target organ damage in middle-aged men and women. J Hum Hypertens. 2015;29(12):719–25. doi:10.1038/jhh.2015.18.
18. Madden JM, O’Flynn AM, Fitzgerald AP, Kearney PM. Correlation between short-term blood pressure variability and left-ventricular mass index: a meta-analysis. Hypertens Res. 2015. doi:10.1038/hr.2015.126.
19. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111(14):1777–83. doi:10.1161/01.CIR.0000160923.04524.5B.
20. O’Brien E, Parati G, Stergiou G. Ambulatory blood pressure measurement: what is the international consensus? Hypertension. 2013;62(6):988–94. doi:10.1161/HYPERTENSIONAHA.113.02148.
21. Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282(6):539–46.
22. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51(1):55–61. doi:10.1161/HYPERTENSIONAHA.107.100727.
23. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348(24):2407–15. doi:10.1056/NEJMoa022273.
24. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension. 2011;57(1):3–10. doi:10.1161/HYPERTENSIONAHA.109.133900.
25. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension. 2006;47(2):149–54. doi:10.1161/01.HYP.0000198541.12640.0f.
26. Kario K. Prognosis in relation to blood pressure variability: pro side of the argument. Hypertension. 2015;65(6):1163–9. doi:10.1161/HYPERTENSIONAHA.115.04800. discussion 9.
27. Turak O, Afsar B, Ozcan F, Canpolat U, Grbovic E, Mendi MA, et al. Relationship between elevated morning blood pressure surge, uric acid, and cardiovascular outcomes in hypertensive patients. J Clin Hypertens (Greenwich). 2014;16(7):530–5. doi:10.1111/jch.12359.
28. Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55(4):1040–8. doi:10.1161/HYPERTENSIONAHA.109.137273.
29. Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Ramundo E, Gentile G, et al. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension. 2012;60(1):34–42. doi:10.1161/HYPERTENSIONAHA.112.191858.
30. Bombelli M, Fodri D, Toso E, Macchiarulo M, Cairo M, Facchetti R, et al. Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population. Hypertension. 2014;64(5):943–50. doi:10.1161/HYPERTENSIONAHA.114.03675.
31. Head GA, Chatzivlastou K, Lukoshkova EV, Jennings GL, Reid CM. A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings. Am J Hypertens. 2010;23(10):1074–81. doi:10.1038/ajh.2010.126.
32. Asayama K, Wei FF, Liu YP, Hara A, Gu YM, Schutte R, et al. Does blood pressure variability contribute to risk stratification? Methodological issues and a review of outcome studies based on home blood pressure. Hypertens Res. 2015;38(2):97–101. doi:10.1038/hr.2014.153.
33. Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375(9718):895–905. doi:10.1016/S0140-6736(10)60308-X.
34. Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9(5):469–80. doi:10.1016/S1474-4422(10)70066-1.
35. Arashi H, Ogawa H, Yamaguchi J, Kawada-Watanabe E, Hagiwara N. Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy). Am J Cardiol. 2015;116(2):236–42. doi:10.1016/j.amjcard.2015.04.011.
36. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011;57(2):160–6. doi:10.1161/HYPERTENSIONAHA.110.162255.
37. Chowdhury EK, Owen A, Krum H, Wing LM, Nelson MR, Reid CM. Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients. J Hypertens. 2014;32(3):525–33. doi:10.1097/HJH.0000000000000028.
38. Hata Y, Muratani H, Kimura Y, Fukiyama K, Kawano Y, Ashida T, et al. Office blood pressure variability as a predictor of acute myocardial infarction in elderly patients receiving antihypertensive therapy. J Hum Hypertens. 2002;16(2):141–6. doi:10.1038/sj.jhh.1001301.
39. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375(9718):906–15. doi:10.1016/S0140-6736(10)60235-8.
40. Stergiou GS, Nasothimiou EG. Home monitoring is the optimal method for assessing blood pressure variability. Hypertens Res. 2011;34(12):1246–8. doi:10.1038/hr.2011.145.
41. Parati G, Bilo G. Clinical relevance of day-by-day blood pressure and heart rate variability: new information from home self-measurements. Hypertension. 2008;52(6):1006–8. doi:10.1161/HYPERTENSIONAHA.108.115212.
42. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension. 2012;59(2):212–8. doi:10.1161/HYPERTENSIONAHA.111.178657.
43. Hashimoto T, Kikuya M, Ohkubo T, Satoh M, Metoki H, Inoue R, et al. Home blood pressure level, blood pressure variability, smoking, and stroke risk in Japanese men: the Ohasama study. Am J Hypertens. 2012;25(8):883–91. doi:10.1038/ajh.2012.62.
44. Matsui Y, Ishikawa J, Eguchi K, Shibasaki S, Shimada K, Kario K. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension. 2011;57(6):1087–93. doi:10.1161/HYPERTENSIONAHA.111.171645.
45. Tamura K, Azushima K, Umemura S. Day-by-day home-measured blood pressure variability: another important factor in hypertension with diabetic nephropathy? Hypertens Res. 2011;34(12):1249–50. doi:10.1038/hr.2011.149.
46. Schutte R, Thijs L, Liu YP, Asayama K, Jin Y, Odili A, et al. Within-subject blood pressure level—not variability—predicts fatal and nonfatal outcomes in a general population. Hypertension. 2012;60(5):1138–47. doi:10.1161/HYPERTENSIONAHA.112.202143.
47. Brickman AM, Reitz C, Luchsinger JA, Manly JJ, Schupf N, Muraskin J, et al. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol. 2010;67(5):564–9. doi:10.1001/archneurol.2010.70.
48. Masugata H, Senda S, Murao K, Inukai M, Hosomi N, Iwado Y, et al. Visit-to-visit variability in blood pressure over a 1-year period is a marker of left ventricular diastolic dysfunction in treated hypertensive patients. Hypertens Res. 2011;34(7):846–50. doi:10.1038/hr.2011.54.
49. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens: JASH. 2011;5(3):184–92. doi:10.1016/j.jash.2011.03.001.
50. Kawai T, Ohishi M, Kamide K, Onishi M, Takeya Y, Tatara Y, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res. 2012;35(2):239–43. doi:10.1038/hr.2011.170.
51. Muntner P, Whittle J, Lynch AI, Colantonio LD, Simpson LM, Einhorn PT, et al. Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality: a cohort study. Ann Intern Med. 2015;163(5):329–38. doi:10.7326/M14-2803. The author did a cohort study as a secondary analysis using data from a large, prospective, randomized study. They concluded that the highest versus the lowest SD of SBP (visi-to-visit) was associated with a more CV outcomes (coronary artery disease, stroke, heart failure, and mortality).
52. Shimbo D, Newman JD, Aragaki AK, LaMonte MJ, Bavry AA, Allison M, et al. Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women’s Health Initiative. Hypertension. 2012;60(3):625–30. doi:10.1161/HYPERTENSIONAHA.112.193094.
53. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens. 2012;30(6):1241–51. doi:10.1097/HJH.0b013e32835339ac.
54. Manios E, Tsagalis G, Tsivgoulis G, Barlas G, Koroboki E, Michas F, et al. Time rate of blood pressure variation is associated with impaired renal function in hypertensive patients. J Hypertens. 2009;27(11):2244–8. doi:10.1097/HJH.0b013e328330a94f.
55. Felicio JS, de Souza AC, Kohlmann N, Kohlmann Jr O, Ribeiro AB, Zanella MT. Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes. Cardiovasc Diabetol. 2010;9:36. doi:10.1186/1475-2840-9-36.
56. Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis. 2007;50(6):908–17. doi:10.1053/j.ajkd.2007.07.020.
57. Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med. 2006;166(8):846–52. doi:10.1001/archinte.166.8.846.
58. Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, et al. “Non-dipper” hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol. 1995;43(6):382–7.
59. Jacob P, Hartung R, Bohlender J, Stein G. Utility of 24-h ambulatory blood pressure measurement in a routine clinical setting of patients with chronic renal disease. J Hum Hypertens. 2004;18(10):745–51. doi:10.1038/sj.jhh.1001734.
60. Tsioufis C, Andrikou I, Thomopoulos C, Petras D, Manolis A, Stefanadis C. Comparative prognostic role of nighttime blood pressure and nondipping profile on renal outcomes. Am J Nephrol. 2011;33(3):277–88. doi:10.1159/000324697.
61. Okada T, Matsumoto H, Nagaoka Y, Nakao T. Association of home blood pressure variability with progression of chronic kidney disease. Blood Press Monit. 2012;17(1):1–7. doi:10.1097/MBP.0b013e32834f7125.
62. Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R. Blood pressure variability and multiple organ damage in primary hypertension. J Hum Hypertens. 2013;27(11):663–70. doi:10.1038/jhh.2013.45.
63. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993;11(10):1133–7.
64. Tatasciore A, Zimarino M, Tommasi R, Renda G, Schillaci G, Parati G, et al. Increased short-term blood pressure variability is associated with early left ventricular systolic dysfunction in newly diagnosed untreated hypertensive patients. J Hypertens. 2013;31(8):1653–61. doi:10.1097/HJH.0b013e328361e4a6.
65. Ryu J, Cha RH, Kim DK, Lee JH, Yoon SA, Ryu DR, et al. The clinical association of the blood pressure variability with the target organ damage in hypertensive patients with chronic kidney disease. J Korean Med Sci. 2014;29(7):957–64. doi:10.3346/jkms.2014.29.7.957.
66. Gomez Angelats E, Sierra C, Coca A, Pare JC, de la Sierra A. Lack of association between blood pressure variability and left ventricular hypertrophy in essential hypertension. Med Clin. 2004;123(19):731–4.
67. Kaneda R, Kario K, Hoshide S, Umeda Y, Hoshide Y, Shimada K. Morning blood pressure hyper-reactivity is an independent predictor for hypertensive cardiac hypertrophy in a community-dwelling population. Am J Hypertens. 2005;18(12 Pt 1):1528–33. doi:10.1016/j.amjhyper.2005.06.015.
68. Yano Y, Hoshide S, Inokuchi T, Kanemaru Y, Shimada K, Kario K. Association between morning blood pressure surge and cardiovascular remodeling in treated elderly hypertensive subjects. Am J Hypertens. 2009;22(11):1177–82. doi:10.1038/ajh.2009.162.
69. Vishram JK, Dahlof B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, et al. Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy. J Hypertens. 2015;33(12):2422–30. doi:10.1097/HJH.0000000000000739.
70. Filomena J, Riba-Llena I, Vinyoles E, Tovar JL, Mundet X, Castane X, et al. Short-term blood pressure variability relates to the presence of subclinical brain small vessel disease in primary hypertension. Hypertension. 2015;66(3):634–40. doi:10.1161/HYPERTENSIONAHA.115.05440. discussion 445.
71. Yu JM, Kong QY, Schoenhagen P, Shen T, He YS, Wang JW, et al. The prognostic value of long-term visit-to-visit blood pressure variability on stroke in real-world practice: a dynamic cohort study in a large representative sample of Chinese hypertensive population. Int J Cardiol. 2014;177(3):995–1000. doi:10.1016/j.ijcard.2014.09.149.
72. Bohm M, Schumacher H, Leong D, Mancia G, Unger T, Schmieder R, et al. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk. Hypertension. 2015;65(3):651–61. doi:10.1161/HYPERTENSIONAHA.114.04568.
73. Yano Y, Ning H, Allen N, Reis JP, Launer LJ, Liu K, et al. Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Hypertension. 2014;64(5):983–8. doi:10.1161/HYPERTENSIONAHA.114.03978.
74. Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E, et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension. 2005;45(4):505–12. doi:10.1161/01.HYP.0000158306.87582.43.
75. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 2001;19(11):1981–9.
76. Chen Y, Xiong H, Wu D, Pirbhulal S, Tian X, Zhang R, et al. Relationship of short-term blood pressure variability with carotid intima-media thickness in hypertensive patients. Biomed Eng Online. 2015;14:71. doi:10.1186/s12938-015-0059-8.
77. Song H, Wei F, Liu Z, Zhao Y, Ye L, Lu F, et al. Visit-to-visit variability in systolic blood pressure: correlated with the changes of arterial stiffness and myocardial perfusion in on-treated hypertensive patients. Clin Exp Hypertens. 2015;37(1):63–9. doi:10.3109/10641963.2014.897724.
78. Liu Z, Zhao Y, Lu F, Zhang H, Diao Y. Day-by-day variability in self-measured blood pressure at home: effects on carotid artery atherosclerosis, brachial flow-mediated dilation, and endothelin-1 in normotensive and mild-moderate hypertensive individuals. Blood Press Monit. 2013;18(6):316–25. doi:10.1097/MBP.0000000000000001.
79. Nagai M, Kario K. Visit-to-visit blood pressure variability, silent cerebral injury, and risk of stroke. Am J Hypertens. 2013;26(12):1369–76. doi:10.1093/ajh/hpt167.
80. Friberg P, Hallback-Nordlander M, Karlsson B, Ljung B. Circadian rhythm of arterial blood pressure and heart rate in spontaneously hypertensive rats and normotensive control rats. Proceedings of the 4th International Symposium on Rats with Spontaneous Hypertension and Related Studies. 1982:361–3.
81. Ponchon P, Elghozi JL. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats. Eur J Pharmacol. 1996;297(1–2):61–70.
82. Gironacci MM, Cerniello FM, Longo Carbajosa NA, Goldstein J, Cerrato BD. Protective axis of the renin-angiotensin system in the brain. Clin Sci (Lond). 2014;127(5):295–306. doi:10.1042/CS20130450.
83. Casali KR, Dartora DR, Moura M, Bertagnolli M, Irigoyen MC, Bader M et al. Increased vascular sympathetic modulation in mice with Mas receptor deficiency. J Renin-Angiotensin-Aldosterone Syst. 2016;17.
84. Krieger EM. Neurogenic hypertension in the rat. Circ Res. 1964;15:511–21.
85. Irigoyen MC, Moreira ED, Ida F, Pires M, Cestari IA, Krieger EM. Changes of renal sympathetic activity in acute and chronic conscious sinoaortic denervated rats. Hypertension. 1995;26(6 Pt 2):1111–6.
86. Cowley Jr AW, Liard JF, Guyton AC. Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res. 1973;32(5):564–76.
87. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol. 2001;28(9):709–15.
88. Miao CY, Tao X, Guan YF, Yang YC, Chu ZX, Su DF. Aortic remodeling in rats with chronic sinoaortic denervation. Acad J Second Mil Med. 2000;21:734–8.
89. Zhang C, Chen H, Xie HH, Shu H, Yuan WJ, Su DF. Inflammation is involved in the organ damage induced by sinoaortic denervation in rats. J Hypertens. 2003;21(11):2141–8. doi:10.1097/01.hjh.0000098121.00558.55.
90. Moraes-Silva IC, De La Fuente RN, Mostarda C, Rosa K, Flues K, Damaceno-Rodrigues NR, et al. Baroreflex deficit blunts exercise training-induced cardiovascular and autonomic adaptations in hypertensive rats. Clin Exp Pharmacol Physiol. 2010;37(3):e114–20. doi:10.1111/j.1440-1681.2009.05333.x.
91. Mostarda C, Moraes-Silva IC, Moreira ED, Medeiros A, Piratello AC, Consolim-Colombo FM, et al. Baroreflex sensitivity impairment is associated with cardiac diastolic dysfunction in rats. J Card Fail. 2011;17(6):519–25. doi:10.1016/j.cardfail.2011.02.007.
92. Flues K, Moraes-Silva IC, Mostarda C, Souza PR, Diniz GP, Moreira ED, et al. Cardiac and pulmonary arterial remodeling after sinoaortic denervation in normotensive rats. Auton Neurosci: Basic Clin. 2012;166(1–2):47–53. doi:10.1016/j.autneu.2011.10.005. Increase of BPV by SAD, despite not changing BP, induced important adjustments in cardiac (LV and RV) structure and function and pulmonary hypertension. These changes may indicate that isolated BPV can modulate target tissue damage in rats.
93. Tao X, Zhang SH, Shen FM, Su DF. High-level apoptosis is persistent in myocardiocytes of sinoaortic-denervated rats. J Hypertens. 2004;22(3):557–63.
94. Yasuoka S, Kai H, Kajimoto H, Kudo H, Takayama N, Anegawa T, et al. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats. Circ J. 2013;77(6):1474–81.
95. Martinka P, Fielitz J, Patzak A, Regitz-Zagrosek V, Persson PB, Stauss HM. Mechanisms of blood pressure variability-induced cardiac hypertrophy and dysfunction in mice with impaired baroreflex. Am J Physiol Regul Integr Comp Physiol. 2005;288(3):R767–76. doi:10.1152/ajpregu.00445.2004.
96. Sirvente RA, Irigoyen MC, Souza LE, Mostarda C, La Fuente RN, Candido GO, et al. Cardiac impairment evaluated by transesophageal echocardiography and invasive measurements in rats undergoing sinoaortic denervation. PLoS One. 2014;9(5):e87935. doi:10.1371/journal.pone.0087935.
97. Kudo H, Kai H, Kajimoto H, Koga M, Takayama N, Mori T, et al. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation. Hypertension. 2009;54(4):832–8. doi:10.1161/HYPERTENSIONAHA.109.135905.
98. Kai H, Griendling KK, Lassegue B, Ollerenshaw JD, Runge MS, Alexander RW. Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension. 1994;24(4):523–7.
99. Mostarda C, Rodrigues B, Vane M, Moreira ED, Rosa KT, Moraes-Silva IC, et al. Autonomic impairment after myocardial infarction: role in cardiac remodelling and mortality. Clin Exp Pharmacol Physiol. 2010;37(4):447–52. doi:10.1111/j.1440-1681.2009.05327.x.
100. Mostarda CT, Rodrigues B, de Moraes OA, Moraes-Silva IC, Arruda PB, Cardoso R, et al. Low intensity resistance training improves systolic function and cardiovascular autonomic control in diabetic rats. J Diabetes Complicat. 2014;28(3):273–8. doi:10.1016/j.jdiacomp.2013.12.005.
101. Perrino C, Naga Prasad SV, Mao L, Noma T, Yan Z, Kim HS, et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest. 2006;116(6):1547–60. doi:10.1172/JCI25397.
102. Aoki Y, Kai H, Kajimoto H, Kudo H, Takayama N, Yasuoka S, et al. Large blood pressure variability aggravates arteriolosclerosis and cortical sclerotic changes in the kidney in hypertensive rats. Circ J. 2014;78(9):2284–91. Large BPV, induced by SAD, aggravates pre-glomerular arteriolosclerosis, which results in the cortical sclerotic changes in SHRs through a local angiotensin II-mediated mechanism.
103. Du WM, Miao CY, Liu JG, Shen FM, Yang XQ, Su DF. Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 2003;41(2):233–9.
104. Liu JG, Xu LP, Chu ZX, Miao CY, Su DF. Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats. J Hypertens. 2003;21(10):1961–7. doi:10.1097/01.hjh.0000084762.37215.e7.
105. Sueta D, Koibuchi N, Hasegawa Y, Toyama K, Uekawa K, Katayama T, et al. Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade. Atherosclerosis. 2014;236(1):101–7. doi:10.1016/j.atherosclerosis.2014.06.016.
106. Lu ZA, Xie HH, Xu LP, Yin AF, Miao CY, Su DF. Restoration of arterial baroreflex function contributes to organ protection in spontaneously hypertensive rats treated with long-term hydrochlorothiazide mixture. Clin Exp Pharmacol Physiol. 2003;30(1–2):49–54.
107. Ling G, Liu AJ, Shen FM, Cai GJ, Liu JG, Su DF. Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats. Acta Pharmacol Sin. 2007;28(11):1755–60. doi:10.1111/j.1745-7254.2007.00630.x.
108. Han P, Shen FM, Xie HH, Chen YY, Miao CY, Mehta JL, et al. The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats. J Cell Mol Med. 2009;13(4):726–34. doi:10.1111/j.1582-4934.2008.00365.x.
109. Moreira ED, Mostarda CT, Moraes-Silva IC, Ferreira JB, Dos Santos F, Lacchini S, et al. Effect of simvastatin in the autonomic system is dependent on the increased gain/sensitivity of the baroreceptors. Physiol Rep. 2013;1(3):e00045. doi:10.1002/phy2.45.
110. Takayama N, Kai H, Kudo H, Yasuoka S, Mori T, Anegawa T, et al. Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways. Hypertens Res. 2011;34(3):341–7. doi:10.1038/hr.2010.229.
111. Lataro RM, Silva CA, Tefe-Silva C, Prado CM, Salgado HC. Acetylcholinesterase inhibition attenuates the development of hypertension and inflammation in spontaneously hypertensive rats. Am J Hypertens. 2015;28(10):1201–8. doi:10.1093/ajh/hpv017. Provided evidence that the donepezil, an antiacetylcholinesterase agent that crosses the blood–brain barrier, is capable of producing beneficial effects on BPV, inflammation and target organ damage.
112. Bertagnolli M, Schenkel PC, Campos C, Mostarda CT, Casarini DE, Bello-Klein A, et al. Exercise training reduces sympathetic modulation on cardiovascular system and cardiac oxidative stress in spontaneously hypertensive rats. Am J Hypertens. 2008;21(11):1188–93. doi:10.1038/ajh.2008.270.
113. Bertagnolli M, Casali KR, De Sousa FB, Rigatto K, Becker L, Santos SH, et al. An orally active angiotensin-(1–7) inclusion compound and exercise training produce similar cardiovascular effects in spontaneously hypertensive rats. Peptides. 2014;51:65–73. doi:10.1016/j.peptides.2013.11.006. A compound containing angiotensin 1–7 had benefits on autonomic function and ventricular remodeling similar to aerobic exercise training.
114. Barbosa Neto O, Abate DT, Marocolo Junior M, Mota GR, Orsatti FL, Silva RC R e, et al. Exercise training improves cardiovascular autonomic activity and attenuates renal damage in spontaneously hypertensive rats. J Sports Sci Med. 2013;12(1):52–9.
115. Masson GS, Costa TS, Yshii L, Fernandes DC, Soares PP, Laurindo FR, et al. Time-dependent effects of training on cardiovascular control in spontaneously hypertensive rats: role for brain oxidative stress and inflammation and baroreflex sensitivity. PLoS One. 2014;9(5):e94927. doi:10.1371/journal.pone.0094927.
116. Ceroni A, Chaar LJ, Bombein RL, Michelini LC. Chronic absence of baroreceptor inputs prevents training-induced cardiovascular adjustments in normotensive and spontaneously hypertensive rats. Exp Physiol. 2009;94(6):630–40. doi:10.1113/expphysiol.2008.046128.
117. Parati G, Schumacher H, Bilo G, Mancia G. Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database. J Hypertens. 2010;28(11):2177–83. doi:10.1097/HJH.0b013e32833e1150.
118. Zhang Y, Agnoletti D, Safar ME, Blacher J. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. Hypertension. 2011;58(2):155–60. doi:10.1161/HYPERTENSIONAHA.111.174383.
119. Hermida RC, Ayala DE, Mojon A, Fontao MJ, Fernandez JR. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int. 2011;28(7):601–10. doi:10.3109/07420528.2011.589935.
120. Matsui Y, O’Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension. 2012;59(6):1132–8. doi:10.1161/HYPERTENSIONAHA.111.189217.
121. Levi-Marpillat N, Macquin-Mavier I, Tropeano AI, Parati G, Maison P. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension. Hypertens Res. 2014;37(6):585–90. doi:10.1038/hr.2014.33.
122. Parati G, Dolan E, Ley L, Schumacher H. Impact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring database. J Hypertens. 2014;32(6):1326–33. doi:10.1097/HJH.0000000000000169.
123. Webb AJ, Wilson M, Lovett N, Paul N, Fischer U, Rothwell PM. Response of day-to-day home blood pressure variability by antihypertensive drug class after transient ischemic attack or nondisabling stroke. Stroke. 2014;45(10):2967–73. doi:10.1161/STROKEAHA.114.005982.
124. Karpov YA, Gorbunov VM, Deev AD. Effectiveness of fixed-dose perindopril/amlodipine on clinic, ambulatory and self-monitored blood pressure and blood pressure variability: an open-label, non comparative study in the general practice. High Blood Press Cardiovasc Prev. 2015;22(4):417–25. doi:10.1007/s40292-015-0117-0.
125. Shiga Y, Miura S, Adachi S, Suematsu Y, Sugihara M, Iwata A, et al. Visit-to-visit variability and seasonal variation in blood pressure with single-pill fixed-dose combinations of angiotensin II receptor blocker/calcium channel blocker and angiotensin ii receptor blocker/diuretic in hypertensive patients. J Clin Med Res. 2015;7(10):802–6. doi:10.14740/jocmr2292w.
126. Wijsman LW, de Craen AJ, Muller M, Sabayan B, Stott D, Ford I, et al. Blood pressure lowering medication, visit-to-visit blood pressure variability, and cognitive function in old age. Am J Hypertens. 2015. doi:10.1093/ajh/hpv101.
127. Rakugi H, Ogihara T, Saruta T, Kawai T, Saito I, Teramukai S, et al. Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis. J Hypertens. 2015;33(10):2165–72. doi:10.1097/HJH.0000000000000668.
128. Sato N, Saijo Y, Sasagawa Y, Morimoto H, Takeuchi T, Sano H, et al. Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysis. Clin Exp Hypertens. 2015;37(5):411–9. doi:10.3109/10641963.2014.995802.
129. Mancia G, Omboni S, Chazova I, Coca A, Girerd X, Haller H, et al. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database. J Hypertens. 2016;34(1):139–48. doi:10.1097/HJH.0000000000000767.
130. Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T. Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial. Hypertens Res. 2016;39(1):46–53. doi:10.1038/hr.2015.104.